The above-mentioned association between hereditary hypofibrinogenemia and APO-B-lipoproteinemia represents a new syndrome, characterized by a mutation in the fibrinogen gamma chain gene that provokes a secondary acquired obligatory retention of another protein that per se is normal [16,89,98,99]. The gene discussed is FGG; the disease is Hypofibrinogenemia.